Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT05076656 - EPI-MICROBIO - Fecal microbiota transplantation (FMT) vs Lactobacillus fermentum D3 vs placebo & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview

NCT05076656 - Fecal microbiota transplantation (FMT) vs Lactobacillus fermentum D3 vs placebo & Type 2 diabetes (T2D) is a randomized early clinical phase I basic science trial to study Fecal microbiota transplantation (FMT) or Lactobacillus fermentum D3 or placebo in patients with Type 2 diabetes (T2D)

Primary outcome measures

Changes in Homeostasis Model Assessment of fasting Insulin Resistance (HOMA-IR: glucose (mmol/l( x insulin (pmol/l)/22.5)

Results

Published results could not be found as of February 2026

…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!